US Stock MarketDetailed Quotes

ALLR Allarity Therapeutics

Watchlist
  • 0.9901
  • -0.0399-3.87%
Close Dec 20 16:00 ET
  • 1.0097
  • +0.0196+1.98%
Post 20:01 ET
4.39MMarket Cap-0.14P/E (TTM)

Allarity Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-1.25%-5.44M
-189.10%-7.22M
53.55%-1.49M
24.21%-12.75M
31.64%-1.67M
-21.96%-5.38M
40.68%-2.5M
44.38%-3.2M
-12.97%-16.82M
43.37%-2.45M
Net income from continuing operations
-160.63%-11.59M
31.55%-1.63M
-14.65%-3.84M
25.89%-11.9M
39.32%-1.72M
11.71%-4.45M
53.36%-2.38M
-8.83%-3.35M
39.74%-16.06M
83.12%-2.84M
Operating gains losses
-370.00%-47K
-12.08%-2.14M
-25.00%-495K
68.20%-5.83M
-4.03%-3.51M
97.14%-10K
-243.45%-1.91M
97.18%-396K
-676.79%-18.34M
-1,830.29%-3.38M
Depreciation and amortization
-44.44%5K
-88.89%1K
-80.00%2K
-38.33%37K
350.00%9K
-18.18%9K
-62.50%9K
-56.52%10K
-43.40%60K
-87.50%2K
Deferred tax
---432K
--0
---14K
106.02%97K
135.93%97K
--0
--0
--0
-8,160.00%-1.61M
-114.29%-270K
Other non cash items
-92.54%57K
-95.91%20K
10.34%96K
1,040.58%1.57M
129.36%234K
820.48%764K
-40.80%489K
234.62%87K
-93.30%138K
-176.34%-797K
Change In working capital
-73.79%-3.16M
-419.48%-3.58M
405.78%2.89M
1,121.95%3.35M
273.58%3.48M
-403.68%-1.82M
70.32%1.12M
122.71%571K
-105.89%-328K
-85.84%931K
-Change in receivables
-508.33%-73K
66.44%-248K
-2,143.48%-516K
---26K
-4.96%748K
93.81%-12K
-435.51%-739K
94.95%-23K
--0
--787K
-Change in prepaid assets
222.16%215K
-53.32%176K
4,083.33%239K
69.26%-190K
-231.90%-385K
-145.71%-176K
10.88%377K
99.51%-6K
-575.38%-618K
-243.21%-116K
-Change in payables and accrued expense
-52.43%-3.33M
-334.01%-3.48M
389.00%3.07M
51.84%2.23M
31.44%2.3M
-647.37%-2.18M
148.00%1.49M
149.02%627K
-75.13%1.47M
-71.68%1.75M
-Change in other current assets
-94.42%31K
-200.00%-21K
621.05%99K
225.35%1.35M
155.97%820K
1,584.85%556K
93.91%-7K
-104.04%-19K
-226.36%-1.08M
-528.76%-1.47M
-Change in other current liabilities
--0
--0
--0
91.92%-8K
--0
--0
--0
65.22%-8K
20.16%-99K
19.23%-21K
Cash from discontinued investing activities
Operating cash flow
-1.25%-5.44M
-189.10%-7.22M
53.55%-1.49M
24.21%-12.75M
31.64%-1.67M
-21.96%-5.38M
40.68%-2.5M
44.38%-3.2M
-12.97%-16.82M
43.37%-2.45M
Investing cash flow
Cash flow from continuing investing activities
0
-21.29%791K
-460.00%-18K
Net PPE purchase and sale
----
----
----
--0
----
----
----
----
---18K
----
Net intangibles purchase and sale
----
----
----
--0
----
----
----
----
-19.50%809K
--0
Cash from discontinued investing activities
Investing cash flow
----
----
----
--0
----
----
----
----
-21.29%791K
-460.00%-18K
Financing cash flow
Cash flow from continuing financing activities
-24.53%4.87M
818.29%26.31M
19.17%1.38M
938.67%11M
-47.80%522K
6.45M
223.97%2.87M
1.16M
-103.88%-1.31M
-94.58%1M
Net issuance payments of debt
--0
41.69%-1.34M
--1.34M
-364.90%-2.65M
-100.10%-1K
---350K
---2.3M
--0
3.20%1M
732.91%1M
Net common stock issuance
-67.86%5.43M
--27.65M
--40K
--16.9M
--0
--16.9M
--0
--0
--0
--0
Net preferred stock issuance
95.24%-562K
--0
--0
-263.60%-5.49M
--0
---11.82M
441.69%5.16M
--1.16M
---1.51M
--0
Proceeds from stock option exercised by employees
--0
----
----
--2.24M
--523K
----
----
----
--0
--0
Net other financing activities
----
----
----
----
----
----
----
----
60.80%-800K
--0
Cash from discontinued financing activities
Financing cash flow
-24.53%4.87M
818.29%26.31M
19.17%1.38M
938.67%11M
-47.80%522K
--6.45M
223.97%2.87M
--1.16M
-103.88%-1.31M
-94.58%1M
Net cash flow
Beginning cash position
4,479.29%19.23M
5.76%312K
-91.82%166K
-89.62%2.03M
-64.55%1.4M
-94.53%420K
-97.97%295K
-89.62%2.03M
6,462.08%19.56M
-29.33%3.95M
Current changes in cash
-153.54%-575K
5,074.25%19.09M
94.76%-107K
89.91%-1.75M
21.45%-1.15M
124.36%1.07M
105.66%369K
58.69%-2.04M
-186.96%-17.34M
-110.37%-1.46M
Effect of exchange rate changes
-105.26%-195K
29.51%-172K
-18.12%253K
40.21%-113K
81.68%-83K
-114.03%-95K
29.89%-244K
575.38%309K
72.21%-189K
-198.03%-453K
End cash Position
1,219.73%18.46M
4,479.29%19.23M
5.76%312K
-91.82%166K
-91.82%166K
-64.55%1.4M
-94.53%420K
-97.97%295K
-89.62%2.03M
-89.62%2.03M
Free cash flow
-1.25%-5.44M
-189.10%-7.22M
53.55%-1.49M
24.29%-12.75M
32.14%-1.67M
-21.96%-5.38M
40.68%-2.5M
44.38%-3.2M
-13.09%-16.84M
42.95%-2.46M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -1.25%-5.44M-189.10%-7.22M53.55%-1.49M24.21%-12.75M31.64%-1.67M-21.96%-5.38M40.68%-2.5M44.38%-3.2M-12.97%-16.82M43.37%-2.45M
Net income from continuing operations -160.63%-11.59M31.55%-1.63M-14.65%-3.84M25.89%-11.9M39.32%-1.72M11.71%-4.45M53.36%-2.38M-8.83%-3.35M39.74%-16.06M83.12%-2.84M
Operating gains losses -370.00%-47K-12.08%-2.14M-25.00%-495K68.20%-5.83M-4.03%-3.51M97.14%-10K-243.45%-1.91M97.18%-396K-676.79%-18.34M-1,830.29%-3.38M
Depreciation and amortization -44.44%5K-88.89%1K-80.00%2K-38.33%37K350.00%9K-18.18%9K-62.50%9K-56.52%10K-43.40%60K-87.50%2K
Deferred tax ---432K--0---14K106.02%97K135.93%97K--0--0--0-8,160.00%-1.61M-114.29%-270K
Other non cash items -92.54%57K-95.91%20K10.34%96K1,040.58%1.57M129.36%234K820.48%764K-40.80%489K234.62%87K-93.30%138K-176.34%-797K
Change In working capital -73.79%-3.16M-419.48%-3.58M405.78%2.89M1,121.95%3.35M273.58%3.48M-403.68%-1.82M70.32%1.12M122.71%571K-105.89%-328K-85.84%931K
-Change in receivables -508.33%-73K66.44%-248K-2,143.48%-516K---26K-4.96%748K93.81%-12K-435.51%-739K94.95%-23K--0--787K
-Change in prepaid assets 222.16%215K-53.32%176K4,083.33%239K69.26%-190K-231.90%-385K-145.71%-176K10.88%377K99.51%-6K-575.38%-618K-243.21%-116K
-Change in payables and accrued expense -52.43%-3.33M-334.01%-3.48M389.00%3.07M51.84%2.23M31.44%2.3M-647.37%-2.18M148.00%1.49M149.02%627K-75.13%1.47M-71.68%1.75M
-Change in other current assets -94.42%31K-200.00%-21K621.05%99K225.35%1.35M155.97%820K1,584.85%556K93.91%-7K-104.04%-19K-226.36%-1.08M-528.76%-1.47M
-Change in other current liabilities --0--0--091.92%-8K--0--0--065.22%-8K20.16%-99K19.23%-21K
Cash from discontinued investing activities
Operating cash flow -1.25%-5.44M-189.10%-7.22M53.55%-1.49M24.21%-12.75M31.64%-1.67M-21.96%-5.38M40.68%-2.5M44.38%-3.2M-12.97%-16.82M43.37%-2.45M
Investing cash flow
Cash flow from continuing investing activities 0-21.29%791K-460.00%-18K
Net PPE purchase and sale --------------0-------------------18K----
Net intangibles purchase and sale --------------0-----------------19.50%809K--0
Cash from discontinued investing activities
Investing cash flow --------------0-----------------21.29%791K-460.00%-18K
Financing cash flow
Cash flow from continuing financing activities -24.53%4.87M818.29%26.31M19.17%1.38M938.67%11M-47.80%522K6.45M223.97%2.87M1.16M-103.88%-1.31M-94.58%1M
Net issuance payments of debt --041.69%-1.34M--1.34M-364.90%-2.65M-100.10%-1K---350K---2.3M--03.20%1M732.91%1M
Net common stock issuance -67.86%5.43M--27.65M--40K--16.9M--0--16.9M--0--0--0--0
Net preferred stock issuance 95.24%-562K--0--0-263.60%-5.49M--0---11.82M441.69%5.16M--1.16M---1.51M--0
Proceeds from stock option exercised by employees --0----------2.24M--523K--------------0--0
Net other financing activities --------------------------------60.80%-800K--0
Cash from discontinued financing activities
Financing cash flow -24.53%4.87M818.29%26.31M19.17%1.38M938.67%11M-47.80%522K--6.45M223.97%2.87M--1.16M-103.88%-1.31M-94.58%1M
Net cash flow
Beginning cash position 4,479.29%19.23M5.76%312K-91.82%166K-89.62%2.03M-64.55%1.4M-94.53%420K-97.97%295K-89.62%2.03M6,462.08%19.56M-29.33%3.95M
Current changes in cash -153.54%-575K5,074.25%19.09M94.76%-107K89.91%-1.75M21.45%-1.15M124.36%1.07M105.66%369K58.69%-2.04M-186.96%-17.34M-110.37%-1.46M
Effect of exchange rate changes -105.26%-195K29.51%-172K-18.12%253K40.21%-113K81.68%-83K-114.03%-95K29.89%-244K575.38%309K72.21%-189K-198.03%-453K
End cash Position 1,219.73%18.46M4,479.29%19.23M5.76%312K-91.82%166K-91.82%166K-64.55%1.4M-94.53%420K-97.97%295K-89.62%2.03M-89.62%2.03M
Free cash flow -1.25%-5.44M-189.10%-7.22M53.55%-1.49M24.29%-12.75M32.14%-1.67M-21.96%-5.38M40.68%-2.5M44.38%-3.2M-13.09%-16.84M42.95%-2.46M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Micron Technology
MU
+3.48%
NVIDIA
NVDA
+3.08%
Intel
INTC
+2.41%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%

Unlock the Full List